BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5262427)

  • 21. [Hydroxyproline excretion as an index for the evaluation of metabolic bone changes].
    Mühlbach R
    Beitr Orthop Traumatol; 1966 Oct; 13(10):606-8. PubMed ID: 5977397
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hydroxyprolinuria in relation to bone metastases in patients with breast cancer].
    Rico Lenza H; Millán Núñez-Cortés J; Rodríguez Mora VI; Espinós Pérez D
    Rev Esp Oncol; 1980; 27(1):61-6. PubMed ID: 7209108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Can the phospho-calcium analysis be simplified?].
    Zakraoui L; Ben Ammar S; Belkahia C; Haddad S; Cheour I
    Tunis Med; 1987 Feb; 65(2):87-9. PubMed ID: 3505125
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydroxyproline.
    Niejadlik DC
    Postgrad Med; 1972 May; 51(5):213-6. PubMed ID: 5025220
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of strontium (85Sr) scintigraphy in the clinical analysis of bone diseases.
    Aho AJ; Einola S; Paasio J
    Ann Chir Gynaecol Fenn; 1973; 62(3):146-54. PubMed ID: 4766915
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of urinary hydroxyproline elimination in the detection of bone metastases secondary to prostatic carcinoma].
    de la Peña J; Cárcamo P; Martínez ME; Martínez-Piñeiro JA
    Actas Urol Esp; 1983; 7(3):199-204. PubMed ID: 6624563
    [No Abstract]   [Full Text] [Related]  

  • 27. [Letter: Significance of hydroxyproline secretion].
    Eberhagen D
    Med Klin; 1973 Oct; 68(41):1342. PubMed ID: 4765407
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fractionation of hydroxyproline-containing urinary peptides by Sephadex gel filtration].
    Hanson H; Wiederanders B
    Clin Chim Acta; 1969 Aug; 25(2):255-62. PubMed ID: 5801391
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary acid mucopolysaccharides and hydroxyproline in skeletal disorders.
    Warren RF
    Bull Hosp Joint Dis; 1973 Oct; 34(2):226-33. PubMed ID: 4272716
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydroxyproline excretion in malignant neoplastic disease.
    Hosley HF; Taft EG; Olson KB; Gates S; Beebe RT
    Arch Intern Med; 1966 Dec; 118(6):565-71. PubMed ID: 5925444
    [No Abstract]   [Full Text] [Related]  

  • 31. [Automation of urine hydroxyproline assay after isolation hydrolysis of hypropeptides on ion exchange resin].
    Dakkak R; Dreux C
    Ann Biol Clin (Paris); 1976; 34(3):197-202. PubMed ID: 984526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
    Martoni A; Pedelini G; Colalongo G; Biagi R; Mambelli M; Jafelice G; Rocchetta G; Piana E; Pannuti F
    Minerva Med; 1980 Sep; 71(31):2215-9. PubMed ID: 7422143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urinary hydroxyproline excretion in pneumoconiosis (author's transl)].
    Onizuka R; Kuratomi M; Sugiyama K; Hayashi E; Kitano S; Shibuta S; Kuroki T; Hisamitsu F; Kimura M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 May; 16(5):307-14. PubMed ID: 702955
    [No Abstract]   [Full Text] [Related]  

  • 34. [Basic study on the bone growth--metabolism of MPS and collagen].
    Nakagawa M; Sugiura Y
    Seikei Geka; 1966 Nov; 17(11):845-9. PubMed ID: 4227280
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hydroxyproline excretion in the urine in localized bone diseases].
    Schwägerl W
    Beitr Orthop Traumatol; 1968 Feb; 15(2):84-5. PubMed ID: 5716249
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of the determination of urinary hydroxyproline in the detection of bone metastases].
    Sanz Ortiz J; Mayo Suárez J; Riancho Moral JA; Amado Señarís JA
    Med Clin (Barc); 1983 Sep; 81(7):296-8. PubMed ID: 6645671
    [No Abstract]   [Full Text] [Related]  

  • 37. [Infrared spectroscopy of the dry urinary residue in bone diseases].
    Shafranskiĭ LL; Kushnikov IuA
    Lab Delo; 1973; 3():151-3. PubMed ID: 4129108
    [No Abstract]   [Full Text] [Related]  

  • 38. [The clinical significance of hydroxyproline in the urine].
    Emmrich R; Häntzschel HJ; Häntzschel H
    Z Gesamte Inn Med; 1967 Apr; 22(7):193-9. PubMed ID: 5596343
    [No Abstract]   [Full Text] [Related]  

  • 39. Pyridinoline cross-links as markers for primary and secondary bone tumors.
    Behrens P; Bruns J; Ullrich KP; Açil Y; Gille J
    Scand J Clin Lab Invest; 2003; 63(1):37-44. PubMed ID: 12729068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between maturity, growth and urinary hydroxyproline.
    Pappas AM; Miller ME; Anderson M; Green WT
    Clin Orthop Relat Res; 1971 Jan; 74():241-8. PubMed ID: 5540402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.